The core strength of SEVER Life Sciences lies in the range of products and services our companies offer to patients and customers across the world. Created as a holding company in 2019, Sever brings together four diverse but complementary companies, each with their own specialist focus. As a result, SEVER oversees an unrivalled and uniquely successful series of products, services and technologies. SEVER and the four companies Amring USA, Izvarino, Nordic Pharma and Sever Pharma Solutions are all united by a common purpose : a concern for patients. Located across several continents and with markets across the globe, these companies work tirelessly to put the needs of patients first. These companies discover new drugs for unmet medical needs ; they supply consistent, relevant and high-quality generic drugs ; and they develop, license and manufacture pharmaceutical products. SEVER’s teams not only forge an all-round series of products and services, but also foster a hugely varied expertise With an exchange of technologies, know-how, regulatory support and marketing tools, synergies are generated between the four companies, exploiting the rich talent and full potential of each of them. For instance, ‘Nordimet Pen’, an innovative product in the field of rheumatology, was partly developed, and is manufactured by, Sever Pharma Solutions, and commercialized by Nordic Pharma. Similarly, Sever Pharma Solutions intends to deploy its sterile production centre – which obviates any concerns about contamination – to facilitate greater output of injectable products for both Nordic Pharma and Amring USA. Very few companies the size of SEVER Life Sciences can boast of being able to develop, register, manufacture, license, distribute and market their own pharmaceutical products. Equally, virtually no company of SEVER’s size has the same geographical reach. Our base is Europe but we also have a strong presence in Canada, Japan, Russia and the USA. Our international focus means that where others might see obstacles, we see opportunities. Corporate functions Commercial footprint Manufacturing footprint Address SEVER Life Sciences BV Siriusdreef 41 2132 WT Hoofddorp The Netherlands Contact Phone +41 58 301 0102 E-mail info@severlifesciences.com © SEVER Life Sciences. All rights reserved.

Home > News Show allNewsPress releases Address SEVER Life Sciences BV Siriusdreef 41 2132 WT Hoofddorp The Netherlands Contact Phone +41 58 301 0102 E-mail info@severlifesciences.com © SEVER Life Sciences. All rights reserved.

Home > Contact Contact Please write us. Phone +41 58 301 0102 Email info@severlifesciences.com Aernout P. de Bruijne Director of Finance & Operations Planning Phone +31 (0)6 207 18 634 Email aernout.debruijne@severlifesciences.com Address SEVER Life Sciences B.V Siriusdreef 41 2132 WT Hoofddorp The Netherlands Address SEVER Life Sciences BV Siriusdreef 41 2132 WT Hoofddorp The Netherlands Contact Phone +41 58 301 0102 E-mail info@severlifesciences.com © SEVER Life Sciences. All rights reserved.